_id
690db13cccc777a4e85d0bda
Ticker
ARYC
Name
Arrayit Corporation
Exchange
OTCCE
Address
927 Thompson Place, Sunnyvale, CA, United States, 94085
Country
USA
Sector
Healthcare
Industry
Diagnostics & Research
Currency
USD
Website
https://www.arrayit.com
Description
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.
Last Close
0.0001
Volume
-
Current Price
0.0001
Change
0
Last Updated
2026-01-20T15:42:35.279Z
Image
data:image/webp;base64,UklGRrYDAABXRUJQVlA4IKoDAABQEwCdASpAAD0APrVQnkwnJKKiKAwA4BaJbACy/5eQpnb+C3e838MXbpc/A3mv8zj0O20Sw7scaqrG8DekTb7D/ekeDGfSmTNRqcm+967d17MvSWTvtma+84Izsv8T7Ihz4v1dSvQZTzlyV79xXDkoGpLsprhDWqR0kYjFGpIrJaIB8Ft2wvxNdiD1wyHxZPeAO9fcKhKOt87jaDKOw+k2mUwAAP7+ewaeYf9j2vEFXgWZaEh/zgDlS+KKKLtOzC9p7ld/FbkiOhfufmRo1dFXzOfOt1G6PeCGbTzykWAKP3Fc0bhXiwUK0nj5xu2ipv058/tHqPy2hWuYWprPK+XRRnyTM6c4dt0tpWOXHtOAYgzqmggj7onEjyV7yf1OMeSuiSf0UJgdez+46m+wk4i3PZ/X0AxAiWwLq+vMT1itihBX+5rPAJe0k/P5WcZ2Dwi2k9Vx+OCpRtTlwUuuDQORlcKU0juDBcFTGwgsSJ3wjI+mpQ4njMCcszWDA27emneHx3azpPr+K6XWD+GaYbrsMlJvXy70PRCV00mlpBfVW6UxhLLvMjvh7GrcMxRHYusabDcbUhBBZ/2duCoTevxqTQD39YNVV0+YsbNmdldQ3QIMV6v2DquVY1E8Ks/ukMs4cYjDcO4V45JyiJRO3mKaLh2t+BD46Cy59DZtxnr2gK5F/gVXKsoySXmvs3D5BKfFlyir1hwatUI8JarRNc4nen4KJ3EaV4vr4/zbvdH4BaPAhYAr1KtjJxXluOFOYND+2oZ3Z/jVsU1m5EPEXoAcNSwamcwIDmzbhFI3ZWOxYQQN1+982X8LyOGbYrHGeW2Lc+j0rpFm3T4MPI8OxS+OkjQS1deq/WGmzyUPAt0jZSEjbg0p8H6vsx0AJDXNv/pR4hQ5yDkhhlFTOphitvNGPrHH1wy2bhh2RRr8mAq+LrOHVjNnksgrPEDO0cpBGPBjxHEoytB9D67vgkD2pldFAsZ6LZ/7M+ZaLMbIMx2fEvY/NBZb/SKCDB1zGWUnoW2maOBcTyEckw5QmvWadMJ227quRy4oyglxTDkSDIpLLHLa7J2bHeg7g3losxF88cFWSjbpv9vGdBltytWVOMENczoTA7ZrVVeHfLQkKVx6FhqrlJGvdcp/qr50xB9k7z0Gpoley+KRcJTpQyw1W3M8hHdxW9RCZYg1XWdMlPgxW52swsjaaHHQAJjMCxToCNs9HBq4tj5861cOpeej7MBgWHBYtx4YK3gAAA==
Ipo Date
-
Market Cap
112650
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2015-09-30
Revenue
615151
Cost Of Revenue
244105
Gross Profit
371046
Operating Expenses
3812650
Operating Income
-3197499
Interest Expense
101658
Pretax Income
-3156361
Net Income
-3156361
Eps
-
Dividends Per Share
-
Shares Outstanding
1126502244
Income Tax Expense
0
EBITDA
-
Operating Margin
-519.7909131253953
Total Other Income Expense Net
41138
Cash
-
Short Term Investments
-
Receivables
209664
Inventories
545726
Total Current Assets
755390
Property Plant Equipment
154176
Total Assets
1009566
Payables
1266662
Short Term Debt
250000
Long Term Debt
-
Total Liabilities
7855263
Equity
-6847306
Bs_currency_symbol
USD
Depreciation
11516
Change In Working Capital
-
Cash From Operations
10727
Capital Expenditures
4314
Cash From Investing
-4314
Cash From Financing
-6413
Net Change In Cash
-
Cf_currency_symbol
USD
PE
-
PB
-
ROE
46.096391778021896
ROA
-312.645334727992
FCF
6413
Fcf Percent
0.010425082621990373
Piotroski FScore
2
Health Score
41
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
8.3
Garp Investing Score
4.5
Growth Investing Score
4.5
Momentum Investing Score
3.5
Net Net Investing Score
1.5
Quality Investing Score
4.5
Value Investing Score
3
Quarters > 0 > quarter
2015-09-30
Quarters > 0 > income Statement > revenue
615151
Quarters > 0 > income Statement > cost Of Revenue
244105
Quarters > 0 > income Statement > gross Profit
371046
Quarters > 0 > income Statement > operating Expenses
3812650
Quarters > 0 > income Statement > operating Income
-3197499
Quarters > 0 > income Statement > interest Expense
101658
Quarters > 0 > income Statement > pretax Income
-3156361
Quarters > 0 > income Statement > net Income
-3156361
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
0
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-519.7909131253953
Quarters > 0 > income Statement > total Other Income Expense Net
41138
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
209664
Quarters > 0 > balance Sheet > inventories
545726
Quarters > 0 > balance Sheet > total Current Assets
755390
Quarters > 0 > balance Sheet > property Plant Equipment
154176
Quarters > 0 > balance Sheet > total Assets
1009566
Quarters > 0 > balance Sheet > payables
1266662
Quarters > 0 > balance Sheet > short Term Debt
250000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
7855263
Quarters > 0 > balance Sheet > equity
-6847306
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-3156361
Quarters > 0 > cash Flow > depreciation
11516
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
10727
Quarters > 0 > cash Flow > capital Expenditures
4314
Quarters > 0 > cash Flow > cash From Investing
-4314
Quarters > 0 > cash Flow > cash From Financing
-6413
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
46.096391778021896
Quarters > 0 > ratios > ROA
-312.645334727992
Quarters > 0 > ratios > FCF
6413
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.010425082621990373
Quarters > 0 > health Score
41
Quarters > 1 > quarter
2015-06-30
Quarters > 1 > income Statement > revenue
573361
Quarters > 1 > income Statement > cost Of Revenue
243439
Quarters > 1 > income Statement > gross Profit
329922
Quarters > 1 > income Statement > operating Expenses
719586
Quarters > 1 > income Statement > operating Income
-146225
Quarters > 1 > income Statement > interest Expense
264038
Quarters > 1 > income Statement > pretax Income
-437734
Quarters > 1 > income Statement > net Income
-437734
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
0
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-25.50312979082986
Quarters > 1 > income Statement > total Other Income Expense Net
-291509
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
271448
Quarters > 1 > balance Sheet > inventories
517068
Quarters > 1 > balance Sheet > total Current Assets
788516
Quarters > 1 > balance Sheet > property Plant Equipment
161378
Quarters > 1 > balance Sheet > total Assets
1049894
Quarters > 1 > balance Sheet > payables
1090850
Quarters > 1 > balance Sheet > short Term Debt
250000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
7958846
Quarters > 1 > balance Sheet > equity
-6909061
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-437734
Quarters > 1 > cash Flow > depreciation
10294
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-90593
Quarters > 1 > cash Flow > capital Expenditures
6948
Quarters > 1 > cash Flow > cash From Investing
-6948
Quarters > 1 > cash Flow > cash From Financing
38780
Quarters > 1 > cash Flow > net Change In Cash
-58761
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
6.33565111091073
Quarters > 1 > ratios > ROA
-41.693161404865634
Quarters > 1 > ratios > FCF
-97541
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-0.170121441814145
Quarters > 1 > health Score
30
Quarters > 2 > quarter
2015-03-31
Quarters > 2 > income Statement > revenue
787038
Quarters > 2 > income Statement > cost Of Revenue
402915
Quarters > 2 > income Statement > gross Profit
384123
Quarters > 2 > income Statement > operating Expenses
1669090
Quarters > 2 > income Statement > operating Income
-882052
Quarters > 2 > income Statement > interest Expense
169169
Quarters > 2 > income Statement > pretax Income
-1473322
Quarters > 2 > income Statement > net Income
-1473322
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
0
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-112.07235228794544
Quarters > 2 > income Statement > total Other Income Expense Net
-591270
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
58761
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
187353
Quarters > 2 > balance Sheet > inventories
477202
Quarters > 2 > balance Sheet > total Current Assets
723316
Quarters > 2 > balance Sheet > property Plant Equipment
164724
Quarters > 2 > balance Sheet > total Assets
988040
Quarters > 2 > balance Sheet > payables
1010523
Quarters > 2 > balance Sheet > short Term Debt
250000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
8024110
Quarters > 2 > balance Sheet > equity
-7036179
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-1473322
Quarters > 2 > cash Flow > depreciation
9941
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-138371
Quarters > 2 > cash Flow > capital Expenditures
6948
Quarters > 2 > cash Flow > cash From Investing
-6948
Quarters > 2 > cash Flow > cash From Financing
174545
Quarters > 2 > cash Flow > net Change In Cash
36174
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
20.93923420652033
Quarters > 2 > ratios > ROA
-149.11562284927734
Quarters > 2 > ratios > FCF
-145319
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.1846403858517632
Quarters > 2 > health Score
41
Quarters > 3 > quarter
2014-12-31
Quarters > 3 > income Statement > revenue
844746
Quarters > 3 > income Statement > cost Of Revenue
537899
Quarters > 3 > income Statement > gross Profit
306847
Quarters > 3 > income Statement > operating Expenses
1221565
Quarters > 3 > income Statement > operating Income
-376819
Quarters > 3 > income Statement > interest Expense
105558
Quarters > 3 > income Statement > pretax Income
-2498846
Quarters > 3 > income Statement > net Income
-2498846
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
0
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-44.60737310386791
Quarters > 3 > income Statement > total Other Income Expense Net
-2122027
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
22587
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
198195
Quarters > 3 > balance Sheet > inventories
464192
Quarters > 3 > balance Sheet > total Current Assets
725724
Quarters > 3 > balance Sheet > property Plant Equipment
174665
Quarters > 3 > balance Sheet > total Assets
1000389
Quarters > 3 > balance Sheet > payables
1059752
Quarters > 3 > balance Sheet > short Term Debt
250000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
7496593
Quarters > 3 > balance Sheet > equity
-6496313
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2498846
Quarters > 3 > cash Flow > depreciation
9927
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-468472
Quarters > 3 > cash Flow > capital Expenditures
815
Quarters > 3 > cash Flow > cash From Investing
815
Quarters > 3 > cash Flow > cash From Financing
470457
Quarters > 3 > cash Flow > net Change In Cash
2800
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
38.46560348924074
Quarters > 3 > ratios > ROA
-249.7874326886841
Quarters > 3 > ratios > FCF
-469287
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.5555362203549943
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2014-12-31
Annuals > 0 > income Statement > revenue
4377300
Annuals > 0 > income Statement > cost Of Revenue
1802242
Annuals > 0 > income Statement > gross Profit
2575058
Annuals > 0 > income Statement > operating Expenses
5870717
Annuals > 0 > income Statement > operating Income
-1493417
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-3315594
Annuals > 0 > income Statement > net Income
-3315594
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
0
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-34.11730975715624
Annuals > 0 > income Statement > total Other Income Expense Net
-1822177
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
22587
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
198195
Annuals > 0 > balance Sheet > inventories
464192
Annuals > 0 > balance Sheet > total Current Assets
725724
Annuals > 0 > balance Sheet > property Plant Equipment
174665
Annuals > 0 > balance Sheet > total Assets
1000389
Annuals > 0 > balance Sheet > payables
1059752
Annuals > 0 > balance Sheet > short Term Debt
250000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
7496593
Annuals > 0 > balance Sheet > equity
-6496313
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3315594
Annuals > 0 > cash Flow > depreciation
40398
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-749721
Annuals > 0 > cash Flow > capital Expenditures
136578
Annuals > 0 > cash Flow > cash From Investing
-136578
Annuals > 0 > cash Flow > cash From Financing
618227
Annuals > 0 > cash Flow > net Change In Cash
-268072
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
51.03808883592893
Annuals > 0 > ratios > ROA
-331.4304735457907
Annuals > 0 > ratios > FCF
-886299
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.20247618394900965
Annuals > 0 > health Score
41
Annuals > 1 > quarter
2013-12-31
Annuals > 1 > income Statement > revenue
2902135
Annuals > 1 > income Statement > cost Of Revenue
1777348
Annuals > 1 > income Statement > gross Profit
1124787
Annuals > 1 > income Statement > operating Expenses
3682066
Annuals > 1 > income Statement > operating Income
-779931
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-381894
Annuals > 1 > income Statement > net Income
-381894
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
0
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-26.874387304518915
Annuals > 1 > income Statement > total Other Income Expense Net
398037
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
290659
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
401467
Annuals > 1 > balance Sheet > inventories
457678
Annuals > 1 > balance Sheet > total Current Assets
1340296
Annuals > 1 > balance Sheet > property Plant Equipment
78485
Annuals > 1 > balance Sheet > total Assets
1537705
Annuals > 1 > balance Sheet > payables
1028943
Annuals > 1 > balance Sheet > short Term Debt
250000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
7142744
Annuals > 1 > balance Sheet > equity
-5605148
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-381894
Annuals > 1 > cash Flow > depreciation
40398
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-1859701
Annuals > 1 > cash Flow > capital Expenditures
57446
Annuals > 1 > cash Flow > cash From Investing
-57446
Annuals > 1 > cash Flow > cash From Financing
2207288
Annuals > 1 > cash Flow > net Change In Cash
290141
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
6.813272370328134
Annuals > 1 > ratios > ROA
-24.835322769972134
Annuals > 1 > ratios > FCF
-1917147
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-0.6605988349956153
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2012-12-31
Annuals > 2 > income Statement > revenue
2491834
Annuals > 2 > income Statement > cost Of Revenue
1273744
Annuals > 2 > income Statement > gross Profit
1218090
Annuals > 2 > income Statement > operating Expenses
4539723
Annuals > 2 > income Statement > operating Income
-2047889
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-576470
Annuals > 2 > income Statement > net Income
229134
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
0
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-82.18400583666488
Annuals > 2 > income Statement > total Other Income Expense Net
1471419
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
518
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
227743
Annuals > 2 > balance Sheet > inventories
316807
Annuals > 2 > balance Sheet > total Current Assets
547318
Annuals > 2 > balance Sheet > property Plant Equipment
-
Annuals > 2 > balance Sheet > total Assets
565683
Annuals > 2 > balance Sheet > payables
1501267
Annuals > 2 > balance Sheet > short Term Debt
275000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
8207828
Annuals > 2 > balance Sheet > equity
-7642256
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
229134
Annuals > 2 > cash Flow > depreciation
16310
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
30023
Annuals > 2 > cash Flow > capital Expenditures
57446
Annuals > 2 > cash Flow > cash From Investing
-96
Annuals > 2 > cash Flow > cash From Financing
-30928
Annuals > 2 > cash Flow > net Change In Cash
-1001
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-2.9982507783042074
Annuals > 2 > ratios > ROA
40.505724937818535
Annuals > 2 > ratios > FCF
-27423
Annuals > 2 > ratios > Piotroski FScore
3
Annuals > 2 > ratios > fcf Percent
-0.011005147212856073
Annuals > 2 > health Score
38
Annuals > 3 > quarter
2011-12-31
Annuals > 3 > income Statement > revenue
3811578
Annuals > 3 > income Statement > cost Of Revenue
2310008
Annuals > 3 > income Statement > gross Profit
1501570
Annuals > 3 > income Statement > operating Expenses
3750628
Annuals > 3 > income Statement > operating Income
60950
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-248618
Annuals > 3 > income Statement > net Income
-198740
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
0
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
1.5990752386544367
Annuals > 3 > income Statement > total Other Income Expense Net
-309568
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1519
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
276954
Annuals > 3 > balance Sheet > inventories
180638
Annuals > 3 > balance Sheet > total Current Assets
461361
Annuals > 3 > balance Sheet > property Plant Equipment
16310
Annuals > 3 > balance Sheet > total Assets
496036
Annuals > 3 > balance Sheet > payables
1179108
Annuals > 3 > balance Sheet > short Term Debt
370011
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8504417
Annuals > 3 > balance Sheet > equity
-7971843
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-198740
Annuals > 3 > cash Flow > depreciation
27092
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
199437
Annuals > 3 > cash Flow > capital Expenditures
3290
Annuals > 3 > cash Flow > cash From Investing
-3290
Annuals > 3 > cash Flow > cash From Financing
-205461
Annuals > 3 > cash Flow > net Change In Cash
-9314
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
2.4930245113959217
Annuals > 3 > ratios > ROA
-40.06564039706795
Annuals > 3 > ratios > FCF
196147
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.051460838529344015
Annuals > 3 > health Score
32
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
46.096391778021896
Profitability > metrics > ROA
-417.84521902593366
Profitability > metrics > Net Margin
-5.131034493969773
Profitability > final Score
40
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-31.453491117275572
Risk > final Score
-96
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.498060873154335
Liquidity > metrics > Quick Ratio
0.13824042535515493
Liquidity > final Score
17
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
13
Prev Profitabilities > 1
40
Prev Profitabilities > 2
40
Prev Risks > 0
28
Prev Risks > 1
9
Prev Risks > 2
16
Prev Liquidities > 0
20
Prev Liquidities > 1
20
Prev Liquidities > 2
20
Updated At
2026-01-20T21:25:02.227Z
Earnings History > 0 > period
2015-09-30
Earnings History > 0 > report Date
2015-11-20
Earnings History > 0 > date
2015-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
USD
Earnings History > 0 > eps Actual
-0.01
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-0.01
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2015-06-30
Earnings History > 1 > report Date
2015-08-19
Earnings History > 1 > date
2015-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.0077
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-0.0077
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2015-03-31
Earnings History > 2 > report Date
2015-04-15
Earnings History > 2 > date
2015-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.05
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.05
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2014-12-31
Earnings History > 3 > report Date
2015-03-31
Earnings History > 3 > date
2014-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.0262
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.0262
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2014-09-30
Earnings History > 4 > report Date
2014-11-19
Earnings History > 4 > date
2014-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.01
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2014-06-30
Earnings History > 5 > report Date
2014-09-30
Earnings History > 5 > date
2014-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0103
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.0103
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2014-03-31
Earnings History > 6 > report Date
2014-06-30
Earnings History > 6 > date
2014-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0113
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.0113
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2013-12-31
Earnings History > 7 > report Date
2014-03-31
Earnings History > 7 > date
2013-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.001
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
0.001
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2013-09-30
Earnings History > 8 > report Date
2013-12-31
Earnings History > 8 > date
2013-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0161
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.0161
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2013-06-30
Earnings History > 9 > report Date
2013-09-30
Earnings History > 9 > date
2013-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0009
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.0009
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2013-03-31
Earnings History > 10 > report Date
2013-06-30
Earnings History > 10 > date
2013-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0026
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.0026
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2012-12-31
Earnings History > 11 > report Date
2013-03-31
Earnings History > 11 > date
2012-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.004
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.004
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2012-09-30
Earnings History > 12 > report Date
2012-12-31
Earnings History > 12 > date
2012-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
0.0067
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0.0067
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2012-06-30
Earnings History > 13 > report Date
2012-09-30
Earnings History > 13 > date
2012-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.0002
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.0002
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2012-03-31
Earnings History > 14 > report Date
2012-06-30
Earnings History > 14 > date
2012-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0022
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.0022
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2011-12-31
Earnings History > 15 > report Date
2012-03-31
Earnings History > 15 > date
2011-12-31
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0314
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
-0.0314
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2011-09-30
Earnings History > 16 > report Date
2011-12-31
Earnings History > 16 > date
2011-09-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.0009
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.0009
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2011-06-30
Earnings History > 17 > report Date
2011-09-30
Earnings History > 17 > date
2011-06-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0033
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.0033
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2011-03-31
Earnings History > 18 > report Date
2011-06-30
Earnings History > 18 > date
2011-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.0049
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.0049
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2010-12-31
Earnings History > 19 > report Date
2011-03-31
Earnings History > 19 > date
2010-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.0002
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.0002
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2010-09-30
Earnings History > 20 > report Date
2010-12-31
Earnings History > 20 > date
2010-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.0252
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.0252
Earnings History > 20 > surprise Percent
-
Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2015-09-30)
Health Score
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
* Institutions hold a combined 0.00% of the total shares of Arrayit Corporation
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2015-09-30
EPS Actual
-0.01
EPS Estimate
0
EPS Difference
-0.01
Surprise Percent
0%
(Last Updated 2015-09-30)
(Last Updated 2015-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2015-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2015-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.